These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7851073)

  • 21. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.
    Araki S; Koya D; Makiishi T; Sugimoto T; Isono M; Kikkawa R; Kashiwagi A; Haneda M
    Diabetes Care; 2003 Aug; 26(8):2416-20. PubMed ID: 12882872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between NAT2 gene polymorphism and cirrhotic portal hypertension in the Chinese population.
    Li XP; Liu Y; Zhang CQ
    Genet Test Mol Biomarkers; 2015 Mar; 19(3):138-43. PubMed ID: 25574899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients.
    Santos KG; Canani LH; Gross JL; Tschiedel B; Souto KE; Roisenberg I
    J Nephrol; 2005; 18(6):733-8. PubMed ID: 16358232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects.
    Nakajima K; Tanaka Y; Nomiyama T; Ogihara T; Ikeda F; Kanno R; Iwashita N; Sakai K; Watada H; Onuma T; Kawamori R
    Diabetes Care; 2003 Mar; 26(3):892-8. PubMed ID: 12610055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic analysis of the NAT2 and CYP2D6 polymorphisms in white patients with non-insulin-dependent diabetes mellitus.
    Agúndez JA; Menaya JG; Tejeda R; Lago F; Chávez M; Benítez J
    Pharmacogenetics; 1996 Oct; 6(5):465-72. PubMed ID: 8946479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between tumour necrosis factor-alpha G-308A polymorphism and risk of nephropathy in obese Chinese type 2 diabetic patients.
    Wang Y; Ng MC; So WY; Ma R; Ko GT; Tong PC; Chan JC
    Nephrol Dial Transplant; 2005 Dec; 20(12):2733-8. PubMed ID: 16141456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NAT2 slow acetylator genotype as an important modifier of breast cancer risk.
    Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K
    Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes.
    Neugebauer S; Baba T; Watanabe T
    Diabetes; 2000 Mar; 49(3):500-3. PubMed ID: 10868974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [PHENOTYPIC POLYMORPHISM OF N-ACETYLTRANSFERASE 2 IN PATIENTS WITH DIABETES MELLITUS].
    Doroshkevych I; Yakovleva O; Kyrychenko O; Zhamba A; Pivtorak K
    Georgian Med News; 2019 Sep; (294):91-97. PubMed ID: 31687957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of MTHFR 1298C with ACE D allele augments the risk of diabetic nephropathy in Western Iran.
    Rahimi Z; Hasanvand A; Felehgari V
    DNA Cell Biol; 2012 Apr; 31(4):553-9. PubMed ID: 21942443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial nitric oxide synthase gene and the development of diabetic nephropathy.
    Shimizu T; Onuma T; Kawamori R; Makita Y; Tomino Y
    Diabetes Res Clin Pract; 2002 Dec; 58(3):179-85. PubMed ID: 12413777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between ACE gene polymorphism and diabetic nephropathy in South Indian patients.
    Viswanathan V; Zhu Y; Bala K; Dunn S; Snehalatha C; Ramachandran A; Jayaraman M; Sharma K
    JOP; 2001 Mar; 2(2):83-7. PubMed ID: 11867868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between the heparan sulfate proteoglycan gene polymorphism and diabetic nephropathy in Japanese NIDDM with proliferative diabetic retinopathy.
    Fujita H; Narita T; Meguro H; Ishii T; Hanyu O; Suzuki K; Ito S
    Ren Fail; 1999 Nov; 21(6):659-64. PubMed ID: 10586428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
    Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
    Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients.
    Lee SJ; Choi MG; Kim DS; Kim TW
    Metabolism; 2006 Jan; 55(1):1-7. PubMed ID: 16324912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects.
    Brocvielle H; Muret P; Goydadin AC; Boone P; Broly F; Kantelip JP; Humbert P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(6):386-92. PubMed ID: 14528063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphic arylamine N-acetyltransferase (NAT2) genes in children with insulin-dependent diabetes mellitus.
    Mrozikiewicz PM; Drakoulis N; Roots I
    Clin Pharmacol Ther; 1994 Dec; 56(6 Pt 1):626-34. PubMed ID: 7995004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic nephropathy is associated with the 5'-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with Type 2 diabetes.
    Liu YF; Wat NM; Chung SS; Ko BC; Lam KS
    Diabet Med; 2002 Feb; 19(2):113-8. PubMed ID: 11874426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strong association between N-acetyltransferase 2 genotype and PD in Hong Kong Chinese.
    Chan DK; Lam MK; Wong R; Hung WT; Wilcken DE
    Neurology; 2003 Mar; 60(6):1002-5. PubMed ID: 12654968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population.
    Ozbek YK; Oztürk T; Tüzüner BM; Calay Z; Ilvan S; Seyhan FM; Kisakesen HI; Oztürk O; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2885-9. PubMed ID: 20683028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.